| Business Type: | Manufacturer Distributor/Wholesaler Importer Seller |
|---|---|
| Main Market: | Worldwide |
| Brands: | Yirdoc |
| No. of Employees: | 100~200 |
| Annual Sales: | 5,000,000-8,000,000 |
| Year Established: | 2015 |
| Export p.c: | 40% - 50% |
| Total Sales: | 1,000,000 |
Qingdao Future Medical Technology Co., Ltd. was founded in 2014. As a national high-tech enterprise in China, our business is global and closely tied to digital solutions for chronic respiratory diseases. Our innovative devices are playing an important role in the aerosol delivery of upper and lower airway diseases.
Our factory is located in the “Academician Valley” of Qingdao city, in which some high-tech and innovative enterprises locate and the research & innovation atmosphere are strong.
We specialized in development of precise nebulized drug delivery products. As a professional manufacturers in medical field, we are granted with ISO13485 quality system. We also get NMPA,FDA,CE certifications for our products.
With the strong R & D and quality control supports, we always enjoy the great and flexible cooperation with world-wide brands on OEM, ODM business.
Innovation is in our DNA. We are dedicated to developing innovative medical devices/management solutions for respiratory patients.
Our production factory in Qingdao City, Shandong province includes non-sterile production workshop, physical and chemical laboratory, and production factory in Changsha City, Hunan province includes sterile production workshop, 10,000-level sterile laboratory, etc. which can meet the production and testing of sterile devices and non-sterile devices at the same time. Our automatical production lines and experienced workers can meet a variety of demands and guarantee fast lead time.
Our laboratory is equipped with state-of-the-art measuring instruments that allow us to conduct aerosol performance analysis. Our team of well-trained researchers meticulously works on generating reliable data in short periods of time to examine drug-device performance. By these means, we are able to support our partners, providing them with analytical services where pretesting of aerosolized formulation does not require GLP compliance.
The analytical services include aerodynamic particle size distribution analysis, laser diffraction particle size analysis, breath simulation studies, output rate studies, residue studies, and delivered dose studies.
